Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Healthtrust
Boehringer Ingelheim
Mallinckrodt
Cantor Fitzgerald
Teva
Colorcon
UBS
Merck

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ramucirumab

« Back to Dashboard

US Patents for Ramucirumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ramucirumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Ramucirumab ➤ Sign Up Carboline derivatives useful in the treatment of cancer PTC Therapeutics, Inc. (South Planfield, NJ) ➤ Sign Up
Ramucirumab ➤ Sign Up Carboline derivatives useful in the inhibition of angiogenesis PTC Therapeutics, Inc. (South Plainfield, NJ) ➤ Sign Up
Ramucirumab ➤ Sign Up P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up
Ramucirumab ➤ Sign Up Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up
Ramucirumab ➤ Sign Up Method of target membrane protein depletion SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ramucirumab

Drugname Country Document Number Estimated Expiration Related US Patent
Ramucirumab Austria 547102 2025-04-18 ➤ Sign Up
Ramucirumab Australia 2005222632 2024-03-15 ➤ Sign Up
Ramucirumab Brazil PI0508814 2024-03-15 ➤ Sign Up
Ramucirumab Canada 2559408 2024-03-15 ➤ Sign Up
Ramucirumab China 102408425 2024-03-15 ➤ Sign Up
Ramucirumab China 1980672 2024-03-15 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Cipla
McKinsey
Dow
Queensland Health
Moodys
Argus Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.